A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)

Clinical trial NCT05543174 · COMPLETED

Trial details

NCT number: NCT05543174
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alagille Syndrome (ALGS)

Start date: 2023-01-16
Primary completion: 2023-10-25
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.